Tuija Heikkinen

Summary

Affiliation: University of Turku
Country: Finland

Publications

  1. ncbi Citalopram in pregnancy and lactation
    Tuija Heikkinen
    Department of Pharmacology and Clinical Pharmacology, University Central Hospital, University of Turku, Itainen Pitkakatu 4, FIN 20520 Turku, Finland
    Clin Pharmacol Ther 72:184-91. 2002
  2. ncbi Pharmacokinetics of fluoxetine and norfluoxetine in pregnancy and lactation
    Tuija Heikkinen
    Department of Pharmacology and Clinical Pharmacology, University of Turku and Turku University Central Hospital, Finland
    Clin Pharmacol Ther 73:330-7. 2003
  3. ncbi Placental transfer of quetiapine in relation to P-glycoprotein activity
    Melissa Rahi
    Department of Pharmacology and Clinical Pharmacology, Joint Clinical Biochemistry Laboratory of University of Turku, Turku University Central Hospital, Turku, Finland
    J Psychopharmacol 21:751-6. 2007
  4. ncbi MAO-A and COMT genotypes as possible regulators of perinatal serotonergic symptoms after in utero exposure to SSRIs
    Johanna Hilli
    Department of Pharmacology, Drug Development and Therapeutics, University of Turku, Turku, Finland
    Eur Neuropsychopharmacol 19:363-70. 2009
  5. ncbi Effects of exposure to selective serotonin reuptake inhibitors during pregnancy on serotonergic symptoms in newborns and cord blood monoamine and prolactin concentrations
    Kari Laine
    Department of Pharmacology and Clinical Pharmacology, University of Turku and Turku University Central Hospital, Turku, Finland
    Arch Gen Psychiatry 60:720-6. 2003
  6. ncbi Functional role of P-glycoprotein in the human blood-placental barrier
    Melissa Mölsä
    Department of Pharmacology and Clinical Pharmacology, University of Turku, Finland
    Clin Pharmacol Ther 78:123-31. 2005
  7. ncbi Transfer of proinflammatory cytokines across term placenta
    Riikka Aaltonen
    Department of Obstetrics and Gynecology and the Department of Clinical Pharmacology, Turku University Hospital, Turku, Finland
    Obstet Gynecol 106:802-7. 2005

Collaborators

Detail Information

Publications7

  1. ncbi Citalopram in pregnancy and lactation
    Tuija Heikkinen
    Department of Pharmacology and Clinical Pharmacology, University Central Hospital, University of Turku, Itainen Pitkakatu 4, FIN 20520 Turku, Finland
    Clin Pharmacol Ther 72:184-91. 2002
    ..The aim of this study was to examine the efficacy and safety of citalopram in relation to concentrations of citalopram and its metabolites during pregnancy and lactation...
  2. ncbi Pharmacokinetics of fluoxetine and norfluoxetine in pregnancy and lactation
    Tuija Heikkinen
    Department of Pharmacology and Clinical Pharmacology, University of Turku and Turku University Central Hospital, Finland
    Clin Pharmacol Ther 73:330-7. 2003
    ..The aim of this prospective clinical trial was to investigate the pharmacokinetics of fluoxetine and its active metabolite, norfluoxetine, during pregnancy, delivery, and lactation in mothers and their infants...
  3. ncbi Placental transfer of quetiapine in relation to P-glycoprotein activity
    Melissa Rahi
    Department of Pharmacology and Clinical Pharmacology, Joint Clinical Biochemistry Laboratory of University of Turku, Turku University Central Hospital, Turku, Finland
    J Psychopharmacol 21:751-6. 2007
    ..Administration of P-gp inhibiting drugs with quetiapine is not likely to increase fetal exposure to quetiapine, although the ABCB1 C3435T polymorphism may contribute to inter-individual variation in fetal exposure to quetiapine...
  4. ncbi MAO-A and COMT genotypes as possible regulators of perinatal serotonergic symptoms after in utero exposure to SSRIs
    Johanna Hilli
    Department of Pharmacology, Drug Development and Therapeutics, University of Turku, Turku, Finland
    Eur Neuropsychopharmacol 19:363-70. 2009
    ..The COMT 1947G>A polymorphism may affect the occurrence of respiratory distress symptoms in infants with prenatal SSRI-exposure via a mechanism involving prolactin...
  5. ncbi Effects of exposure to selective serotonin reuptake inhibitors during pregnancy on serotonergic symptoms in newborns and cord blood monoamine and prolactin concentrations
    Kari Laine
    Department of Pharmacology and Clinical Pharmacology, University of Turku and Turku University Central Hospital, Turku, Finland
    Arch Gen Psychiatry 60:720-6. 2003
    ..We aimed to investigate the perinatal sequelae of infants exposed to SSRIs during their fetal life and the relationship of these symptoms to the cord blood monoamine and prolactin concentrations...
  6. ncbi Functional role of P-glycoprotein in the human blood-placental barrier
    Melissa Mölsä
    Department of Pharmacology and Clinical Pharmacology, University of Turku, Finland
    Clin Pharmacol Ther 78:123-31. 2005
    ..In this study we aimed to characterize the role of P-glycoprotein in the blood-placental barrier by use of dually perfused human placenta...
  7. ncbi Transfer of proinflammatory cytokines across term placenta
    Riikka Aaltonen
    Department of Obstetrics and Gynecology and the Department of Clinical Pharmacology, Turku University Hospital, Turku, Finland
    Obstet Gynecol 106:802-7. 2005
    ....